BaseHealth and LABCO will improve access to cutting-edge genomic and personalized healthcare technologies that will serve to improve patient wellness across the world.
Redwood City, CA (PRWEB) December 02, 2014
BaseHealth, the maker of the world’s first comprehensive health management platform, and LABCO, the leading European medical diagnostics group based on a unique network of local and regional clinical laboratories, today announced a strategic partnership in order to expand the accessibility of genomics-driven personalized healthcare.
The partnership with LABCO will provide the implementation, marketing, and support of a co-branded version of BaseHealth’s health management platform across LABCO’s entire network of 50,000 referent physicians and its more than 25 million patients per year. With the adoption and deployment of the BaseHealth platform, LABCO physicians and patients will be able to leverage the power of personalized genomics in tandem with a comprehensive health assessment. LABCO’s network of physicians will now be able to engage their patients in a highly collaborative way, creating personalized action plans that positively impact preventable common complex diseases including type 2 diabetes, stroke, osteoarthritis, heart disease and others.
The BaseHealth platform leverages the broad appeal of genomic data in combination with clinical and behavioral analysis to provide personalized, evidence-based health assessments in collaboration with a user’s physician or health coach. Physicians and health coaches use the platform to effectively engage patients in a lifelong commitment to wellness.
“As part of our mission, we seek to employ new technologies and methods to improve the well-being of the millions of patients in our network, and to give our physicians the best possible tools to do so. We are pleased to have partnered with BaseHealth to bring this leading edge health management platform to our large network of physicians and patients,” said Javier de Echevarria Carreres, Chief Innovation Officer of LABCO. “Together with BaseHealth, we will offer our network the most modern and innovative tools for personalized diagnostics and long-term wellness.”
The initial launch of the platform by LABCO will begin in Spain in 2015 to LABCO’s customer base. LABCO and BaseHealth will then roll out the product to the rest of their Pan-European and South American territories such as Italy, UK, Portugal, France and Brazil.
“With the BaseHealth platform deployed to a large population by such a respected leader in the diagnostics market like LABCO, we are ushering in a new era of personalized health management,” said Jorge Velarde, CEO and President of BaseHealth. “BaseHealth and LABCO will improve access to cutting-edge genomic and personalized healthcare technologies that will serve to improve patient wellness across the world.”
“We are excited to be able to offer to physicians and patients in our network a new tool to allow them have a more comprehensive approach to the management of healthcare,” said Dr. Santiago Valor, Group Chief Medical Officer for LABCO. “This tool will bring unique clinical outcomes to our patients.”
“Our vision is completely aligned with LABCO to deliver personalized health management for everyone using an easy-to-understand platform,” said Hossein Fakhrai-Rad, Ph.D, Chief Scientific Officer and Founder. “Working with LABCO, BaseHealth will support patient-physician collaboration to positively impact the progression to preventable common complex diseases, ultimately improving patient health.”
To learn more about BaseHealth, visit: http://www.basehealth.com.
LABCO Quality Diagnostics is the leading European network in management and services in clinical laboratories, pathology services and imaging, developing its diagnostic activities to help patients, doctors, insurance companies, hospitals, companies, laboratories and other public and private institutions. The company has more than 25 million patients annually and more than 150 laboratories and manages more than 100 hospital labs in Belgium, France, Italy, Portugal, Spain, Switzerland, and United Kingdom, as well as Latin America and Middle East.
With a network of over 5,500 professionals, LABCO Quality Diagnostics performs over 1 million daily lab tests.
You can learn more about the company at: http://www.labco.eu
BaseHealth™ is the world’s first comprehensive health management SaaS platform. By integrating genomic data with medical and behavioral analysis, BaseHealth identifies individual and population health risks and engages healthcare consumers with their physicians or health coaches in a highly collaborative way. BaseHealth’s platform offers a life-long, actionable and impactful healthcare solution that sustains user participation, promote healthy behavior, and positively impacts preventable common complex diseases.
BaseHealth was founded in 2011 by an interdisciplinary team of leading clinical geneticists, healthcare executives, software engineers and physicians in Silicon Valley, California. You can learn more about the company at: http://www.basehealth.com.
BaseHealth. Be well.